Biomarker and clinical data-based predictor tool (MAUXI) for ultrafiltration failure and cardiovascular outcome in peritoneal dialysis patients: a retrospective and longitudinal study.
Eva María Arriero-País, María Auxiliadora Bajo-Rubio, Roberto Arrojo-García, Pilar Sandoval, Guadalupe Tirma González-Mateo, Patricia Albar-Vizcaíno, Gloria Del Peso-Gilsanz, Marta Ossorio-González, Pedro Majano, Manuel López-Cabrera
{"title":"Biomarker and clinical data-based predictor tool (MAUXI) for ultrafiltration failure and cardiovascular outcome in peritoneal dialysis patients: a retrospective and longitudinal study.","authors":"Eva María Arriero-País, María Auxiliadora Bajo-Rubio, Roberto Arrojo-García, Pilar Sandoval, Guadalupe Tirma González-Mateo, Patricia Albar-Vizcaíno, Gloria Del Peso-Gilsanz, Marta Ossorio-González, Pedro Majano, Manuel López-Cabrera","doi":"10.1136/bmjhci-2024-101138","DOIUrl":null,"url":null,"abstract":"<p><strong>Objectives: </strong>To develop a machine learning-based software as a medical device to predict the endurance and outcomes of peritoneal dialysis (PD) patients in real time using effluent-measured biomarkers of the mesothelial-to-mesenchymal transition (MMT).</p><p><strong>Methods: </strong>Retrospective, longitudinal, triple blind study in two independent hospitals (Spain), designed under information-theoretical approaches for feature selection and machine learning-based modelling techniques. A total of 151 (train set) and 32 (validation) PD patients in 1979-2022 were included. PD outcomes were analysed in four categories (endurance, exit from PD, cause of PD end, technical failure) by using MMT biomarkers in effluents and clinical databases.</p><p><strong>Results: </strong>MMT biomarkers and clinical data can predict PD with a mean absolute error of 16.99 months by using an Extra Tree (ET) regressor. Linear discriminant analysis (LDA) discerns among transfer to haemodialysis or death, predicts whether the cause of PD end is ultrafiltration failure (UFF) or cardiovascular disease (CVD) and anticipates the type of CVD (receiver operating characteristic curve under the area>0.71).</p><p><strong>Discussion: </strong>Our combination of longitudinal PD datasets, attribute shrinkage and gold-standard algorithms with overfitting testing and class imbalance ensures robust predictions in PD. Biomarkers displayed proper mutual information and SHapley values, indicating that MMT processes may have a causal relationship in the development of UFF and CVD.</p><p><strong>Conclusions: </strong>MMT biomarkers and clinical data may be associated in a causal manner with ultrafiltration failure (local effect) and cardiovascular events (systemic effect) in PD. The machine learning-based software MAUXI provides applicability of ET-LDA models with ≤38 variables to predict PD endurance and type of PD technique failure related to peritoneal membrane deterioration.</p>","PeriodicalId":9050,"journal":{"name":"BMJ Health & Care Informatics","volume":"32 1","pages":""},"PeriodicalIF":4.4000,"publicationDate":"2025-02-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11873327/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"BMJ Health & Care Informatics","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1136/bmjhci-2024-101138","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"HEALTH CARE SCIENCES & SERVICES","Score":null,"Total":0}
引用次数: 0
Abstract
Objectives: To develop a machine learning-based software as a medical device to predict the endurance and outcomes of peritoneal dialysis (PD) patients in real time using effluent-measured biomarkers of the mesothelial-to-mesenchymal transition (MMT).
Methods: Retrospective, longitudinal, triple blind study in two independent hospitals (Spain), designed under information-theoretical approaches for feature selection and machine learning-based modelling techniques. A total of 151 (train set) and 32 (validation) PD patients in 1979-2022 were included. PD outcomes were analysed in four categories (endurance, exit from PD, cause of PD end, technical failure) by using MMT biomarkers in effluents and clinical databases.
Results: MMT biomarkers and clinical data can predict PD with a mean absolute error of 16.99 months by using an Extra Tree (ET) regressor. Linear discriminant analysis (LDA) discerns among transfer to haemodialysis or death, predicts whether the cause of PD end is ultrafiltration failure (UFF) or cardiovascular disease (CVD) and anticipates the type of CVD (receiver operating characteristic curve under the area>0.71).
Discussion: Our combination of longitudinal PD datasets, attribute shrinkage and gold-standard algorithms with overfitting testing and class imbalance ensures robust predictions in PD. Biomarkers displayed proper mutual information and SHapley values, indicating that MMT processes may have a causal relationship in the development of UFF and CVD.
Conclusions: MMT biomarkers and clinical data may be associated in a causal manner with ultrafiltration failure (local effect) and cardiovascular events (systemic effect) in PD. The machine learning-based software MAUXI provides applicability of ET-LDA models with ≤38 variables to predict PD endurance and type of PD technique failure related to peritoneal membrane deterioration.
目的:开发一种基于机器学习的软件,作为一种医疗设备,利用流出物测量的间皮-间质转化(MMT)生物标志物,实时预测腹膜透析(PD)患者的耐受性和预后。方法:在两家独立医院(西班牙)进行回顾性、纵向、三盲研究,采用信息理论方法进行特征选择和基于机器学习的建模技术。1979-2022年共纳入151例(训练集)和32例(验证)PD患者。通过使用废水中的MMT生物标志物和临床数据库,将PD结果分为四类(耐力、PD退出、PD终点原因、技术失败)进行分析。结果:MMT生物标志物和临床数据通过Extra Tree (ET)回归预测PD,平均绝对误差为16.99个月。线性判别分析(LDA)区分血液透析转移或死亡,预测PD终点的原因是超滤功能衰竭(UFF)还是心血管疾病(CVD),并预测CVD的类型(受体工作特征曲线>0.71下)。讨论:我们将纵向PD数据集、属性收缩和黄金标准算法与过拟合测试和类别不平衡相结合,确保了PD的鲁棒预测。生物标志物显示出适当的互信息和SHapley值,表明MMT过程可能在UFF和CVD的发展中具有因果关系。结论:MMT生物标志物和临床数据可能与PD患者的超滤失败(局部效应)和心血管事件(全身效应)存在因果关系。基于机器学习的软件MAUXI提供了具有≤38个变量的ET-LDA模型的适用性,用于预测与腹膜恶化相关的PD耐力和PD技术失败类型。